Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD, focus on the best and most effective methods of engaging patients who have myasthenia gravis throughout their journey. Bhavaraju-Sanka is the John H.

MG patients reported higher anxiety during COVID-19 due to immunosuppressive treatment risks and potential symptom exacerbation. The study observed increased COVID-19 exposure among MG patients, but ...

For several decades, thymectomy has been an option for the treatment of myasthenia gravis, a rare, long-term, autoimmune neuromuscular disease. This randomized clinical trial, carried out in 67 ...

FOR many years it has been recognized that myasthenia gravis is associated, in a high percentage of cases, with structural abnormalities of the thymus. 1 Many patients, especially the younger ones, ...

A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two ...

A significant proportion of patients who survive COVID-19 develop a constellation of life-altering symptoms that persist long after the initial infection has resolved. This post-COVID-19 syndrome may ...

Energy, exercise, family time and even a job—those are the real-life costs of myasthenia gravis (MG) highlighted in Argenx’s new docuseries about the autoimmune disorder. The three films focus on ...

In patients with myasthenia gravis who are being initiated on eculizumab therapy because their disease is refractory to standard treatments, the safety of an abbreviated washout period in ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas J.

In a retrospective analysis, investigators in Finland studied the risk factors for intensive care unit (ICU) admission among patients with MG. Patients with MG who needed intensive care tended to be ...

A new Yale-led study helps explain why some myasthenia gravis (MG) patients relapse after initially responding to a drug called rituximab, commonly used to treat the incurable autoimmune disease ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Last month a patient of mine came back to the clinic ...